Sabah Malek will present on Co-Development of Targeted Therapeutics and Companion Diagnostics with FDA during the World Companion Diagnostics Summit in Boston, MA held on November 28th, 2011. This workshop will focus on the major regulatory issues that concerns diagnostic and pharmaceutical partners during co-development including the development process, coordination of clinical trials, FDA review of both products, and the impact of the recently proposed draft guidance on both sides of the industry.
Please contact vccambridge for more details.
